Article

Early progressive disease in IDH-mutant grade 2 and 3 astrocytoma without CDKN2A/B homozygous deletions may indicate radiation necrosis

2024-03-28

Abstract excerpt

<title>Abstract</title> <p>Purpose Isocitrate dehydrogenase (IDH)-mutant astrocytoma without cyclin-dependent kinase inhibitor 2A/B (<italic>CDKN2A/B</italic>) homozygous deletion (HD) typically follows a slow clinical course. However, some cases show early progression on MRI, and these characteristics have not been fully reported. This study aimed to elucidate the characteristics of those cases. Methods This r...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 9ad556b7-014b-54d6-a5c1-f84351cf0070
DOI: 10.21203/rs.3.rs-4162168/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Early progressive disease in IDH-mutant grade 2 and 3 astrocytoma without CDKN2A/B homozygous deletions may indicate radiation necrosisDOI 10.21203/rs.3.rs-4162168/v1Read

Treatment outcome of IDH1/2 wildtype CNS WHO grade 4 glioma histologically diagnosed as WHO grade II or III astrocytomas.Semantic proximity Read

Limited efficacy of temozolomide alone for astrocytoma, IDH-mutant, CNS WHO grades 2 or 3.Semantic proximity Read

IDH wild-type grade 2 diffuse astrocytomas: prognostic factors and impact of treatments within molecular subgroups.Semantic proximity Read

Clinical, molecular, and radiological predictors of prognosis in newly diagnosed astrocytoma, IDH-mutant, WHO grade 4.Semantic proximity Read

A threshold for mitotic activity and post-surgical residual volume defines distinct prognostic groups for astrocytoma IDH-mutant.Semantic proximity Read

Clinical Characteristics, Treatment Outcomes, And Genetic Alterations of Radiation-Induced GliomasSemantic proximity Read

Assessment of Therapeutic Outcome and Role of Reirradiation in Patients With Radiation-induced GliomaSemantic proximity Read

Novel insight into histological and molecular astrocytoma, IDH-mutant, Grade 4 by the updated WHO classification of central nervous system tumors.Semantic proximity Read

A comprehensive clinical, molecular, radiological, and surgical analysis for predicting prognosis in isocitrate dehydrogenase-mutant astrocytoma patients.Semantic proximity Read

The early infiltrative phase of GBM hypothesis: are molecular glioblastomas histological glioblastomas in the making? A preliminary multicenter study.Semantic proximity Read

Age is associated with unfavorable neuropathological and radiological features and poor outcome in patients with WHO grade 2 and 3 gliomas.Semantic proximity Read

Clinical significance of histopathological features of paired recurrent gliomas: a cohort study from a single cancer center.Semantic proximity Read